Relative risk reduction is not enough: why cardiorenal trials should routinely report absolute risk reduction and number needed to treat

eClinicalMedicine · Elsevier

Аннотация

Publication date: November 2026 Source: eClinicalMedicine, Volume 101 Author(s): Hussein Zaitoon, Muhammad Abdul-Ghani, Ralph A. DeFronzo

Читать у издателя →

Похожие статьи